Improving tuberculosis treatment using mid-infrared spectroscopy for bedside therapeutic drug monitoring

David J. Rowe; Daniel R. Owens; Milos Nedeljkovic; Callum J. Stirling; Katrina Cathie; Suzanne L. Parker; Saul N. Faust; Goran Z. Mashanovich; James S. Wilkinson

doi:10.1117/12.2649135

13 March 2023 Improving tuberculosis treatment using mid-infrared spectroscopy for bedside therapeutic drug monitoring

David J. Rowe, Daniel R. Owens, Milos Nedeljkovic, Callum J. Stirling, Katrina Cathie, Suzanne L. Parker, Saul N. Faust, Goran Z. Mashanovich, James S. Wilkinson

Author Affiliations +

Proceedings Volume 12426, Silicon Photonics XVIII; 124260G (2023) https://doi.org/10.1117/12.2649135
Event: SPIE OPTO, 2023, San Francisco, California, United States

Abstract

Rifampicin is an antimicrobial drug used to treat tuberculosis. The deterioration of a tuberculosis patient on rifampicin is a serious event with several possible causes. Rapid bedside measurement of rifampicin would enable clinicians to determine if patient deterioration was due to subtherapeutic levels and quickly correct the dosing. It would also support personalised dosing to maximise antimicrobial effectiveness whilst minimising side effects. The optimum therapeutic concentration range is 8 – 24 mg/L. We report ATR-FTIR spectroscopy data for the detection of rifampicin for bedside therapeutic drug monitoring (TDM). We demonstrate a limit of detection of 0.46 mg/L from 20 μL spiked whole blood samples. Using whole blood directly enables bedside measurements because it does not require centrifugation and pipetting to extract plasma, which are generally performed in a central laboratory. The absorption-concentration response had good linearity (R² = 0.998) up to the highest measured concentration of 100 mg/L. We apply this data to the design of a miniaturised mid-infrared sensor for TDM using silicon photonics. We present an analysis of the optimum interaction length for an evanescent waveguide sensor using the absorption of rifampicin and a numerical model to quantify the contributions of different system and device noise sources. These sensors can be made more sensitive than their benchtop equivalent because of the enhanced evanescent electric field strength and the increased power spectral density of tunable quantum cascade lasers.

Conference Presentation

Citation Download Citation

David J. Rowe, Daniel R. Owens, Milos Nedeljkovic, Callum J. Stirling, Katrina Cathie, Suzanne L. Parker, Saul N. Faust, Goran Z. Mashanovich, and James S. Wilkinson "Improving tuberculosis treatment using mid-infrared spectroscopy for bedside therapeutic drug monitoring", Proc. SPIE 12426, Silicon Photonics XVIII, 124260G (13 March 2023); https://doi.org/10.1117/12.2649135

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available